170 related articles for article (PubMed ID: 35996247)
1. LncRNA DSCAM-AS1: A Pivotal Therapeutic Target in Cancer.
Hu C
Mini Rev Med Chem; 2023; 23(5):530-536. PubMed ID: 35996247
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA DSCAM-AS1 functions as an oncogene in non-small cell lung cancer by targeting BCL11A.
Liao J; Xie N
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1087-1092. PubMed ID: 30779076
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
5. Long non-coding RNA Down syndrome cell adhesion molecule-anti-sense 1 promotes gastric carcinoma cell proliferation and migration by regulating the miR-204/TPT1 axis.
Wang N; Yang Y; Jia GZ; Wang K; Zhou S; Zhang B; Zhang ZS; Qiao Q; He XL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S187-S195. PubMed ID: 34372727
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA DSCAM-AS1 upregulates
Zhang S; Ding L; Gao F; Fan H
Biochem Cell Biol; 2020 Oct; 98(5):600-611. PubMed ID: 32379981
[TBL] [Abstract][Full Text] [Related]
7. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
Ma Y; Bu D; Long J; Chai W; Dong J
J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
[TBL] [Abstract][Full Text] [Related]
10. DSCAM-AS1 promotes cervical carcinoma cell proliferation and invasion via sponging miR-338-3p.
Li C; Li X; Zhang Y; Wu L; He J; Jiang N; Zhao H; Liu W
Environ Sci Pollut Res Int; 2022 Aug; 29(39):58906-58914. PubMed ID: 35378649
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.
Qiu Z; Pan XX; You DY
Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483
[TBL] [Abstract][Full Text] [Related]
12. Association of LncRNA PCBP1-AS1 with cancer occurrence and development: A review.
Wu Y; Mou J; Liu Y; Zheng W
Medicine (Baltimore); 2023 Oct; 102(43):e35631. PubMed ID: 37904442
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA (lncRNA) DSCAM-AS1 is upregulated in breast cancer.
Tarighi M; Khalaj-Kondori M; Hosseinzadeh A; Abtin M
Breast Dis; 2021; 40(2):63-68. PubMed ID: 33554879
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA DSCAM-AS1 is associated with poor clinical prognosis and contributes to melanoma development by sponging miR-136.
Huang YL; Xu Q; Wang X
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2888-2897. PubMed ID: 31002140
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DSCAM-AS1 indicates a poor prognosis and modulates cell proliferation, migration and invasion in ovarian cancer via upregulating SOX4.
Li Y; Hao J; Jiang YM; Liu Y; Zhang SH
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4143-4148. PubMed ID: 31173284
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis.
Liang J; Zhang S; Wang W; Xu Y; Kawuli A; Lu J; Xiu X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31737900
[TBL] [Abstract][Full Text] [Related]
17. Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer.
Yadav N; Sunder R; Desai S; Dharavath B; Chandrani P; Godbole M; Dutt A
Breast Cancer Res; 2022 Dec; 24(1):97. PubMed ID: 36578092
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network.
Moradi MT; Fallahi H; Rahimi Z
Mol Biol Rep; 2020 Oct; 47(10):7685-7697. PubMed ID: 33040318
[TBL] [Abstract][Full Text] [Related]
19. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
Niknafs YS; Han S; Ma T; Speers C; Zhang C; Wilder-Romans K; Iyer MK; Pitchiaya S; Malik R; Hosono Y; Prensner JR; Poliakov A; Singhal U; Xiao L; Kregel S; Siebenaler RF; Zhao SG; Uhl M; Gawronski A; Hayes DF; Pierce LJ; Cao X; Collins C; Backofen R; Sahinalp CS; Rae JM; Chinnaiyan AM; Feng FY
Nat Commun; 2016 Sep; 7():12791. PubMed ID: 27666543
[TBL] [Abstract][Full Text] [Related]
20. A Review on the Carcinogenic Roles of DSCAM-AS1.
Ghafouri-Fard S; Khoshbakht T; Taheri M; Ebrahimzadeh K
Front Cell Dev Biol; 2021; 9():758513. PubMed ID: 34708048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]